US6887489B2 - Propionibacterium P-63 for use in direct fed microbials for animal feeds - Google Patents
Propionibacterium P-63 for use in direct fed microbials for animal feeds Download PDFInfo
- Publication number
- US6887489B2 US6887489B2 US10/209,735 US20973502A US6887489B2 US 6887489 B2 US6887489 B2 US 6887489B2 US 20973502 A US20973502 A US 20973502A US 6887489 B2 US6887489 B2 US 6887489B2
- Authority
- US
- United States
- Prior art keywords
- lactobacillus
- lactic acid
- bifidobacterium
- streptococcus
- acid producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 34
- 241000186429 Propionibacterium Species 0.000 title claims abstract description 25
- 230000000813 microbial effect Effects 0.000 title claims abstract description 23
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 94
- 239000004310 lactic acid Substances 0.000 claims abstract description 47
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 47
- 241000282849 Ruminantia Species 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 31
- 208000010444 Acidosis Diseases 0.000 claims abstract description 21
- 208000026545 acidosis disease Diseases 0.000 claims abstract description 21
- 230000007950 acidosis Effects 0.000 claims abstract description 20
- 241000282898 Sus scrofa Species 0.000 claims abstract description 15
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 10
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 20
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 20
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 20
- 235000013339 cereals Nutrition 0.000 claims description 17
- 240000008042 Zea mays Species 0.000 claims description 14
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 14
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 14
- 235000005822 corn Nutrition 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 241000186660 Lactobacillus Species 0.000 claims description 11
- 229940039696 lactobacillus Drugs 0.000 claims description 11
- 235000012054 meals Nutrition 0.000 claims description 7
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 5
- 150000008163 sugars Chemical class 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 240000001929 Lactobacillus brevis Species 0.000 claims description 3
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 claims description 3
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 3
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 3
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 claims description 3
- 241000191998 Pediococcus acidilactici Species 0.000 claims description 3
- 241000191996 Pediococcus pentosaceus Species 0.000 claims description 3
- 241000194017 Streptococcus Species 0.000 claims description 3
- 235000014962 Streptococcus cremoris Nutrition 0.000 claims description 3
- 241000194046 Streptococcus intermedius Species 0.000 claims description 3
- 244000057717 Streptococcus lactis Species 0.000 claims description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 3
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 3
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 3
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 3
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 2
- 244000199866 Lactobacillus casei Species 0.000 claims description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 2
- 241001134659 Lactobacillus curvatus Species 0.000 claims description 2
- 229940017800 lactobacillus casei Drugs 0.000 claims description 2
- 241000194031 Enterococcus faecium Species 0.000 claims 2
- 240000004658 Medicago sativa Species 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 17
- 241000894006 Bacteria Species 0.000 abstract description 15
- 230000008569 process Effects 0.000 abstract description 8
- 241000283690 Bos taurus Species 0.000 description 35
- 235000005911 diet Nutrition 0.000 description 34
- 230000037213 diet Effects 0.000 description 34
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 17
- 229940001447 lactate Drugs 0.000 description 17
- 241000186426 Acidipropionibacterium acidipropionici Species 0.000 description 15
- 210000004767 rumen Anatomy 0.000 description 15
- 235000013325 dietary fiber Nutrition 0.000 description 14
- 241000186425 Acidipropionibacterium jensenii Species 0.000 description 13
- 239000012530 fluid Substances 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 241000186335 Acidipropionibacterium thoenii Species 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 241000186428 Propionibacterium freudenreichii Species 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010024652 Liver abscess Diseases 0.000 description 4
- 241000219823 Medicago Species 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 239000001540 sodium lactate Substances 0.000 description 3
- 229940005581 sodium lactate Drugs 0.000 description 3
- 235000011088 sodium lactate Nutrition 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000011284 combination treatment Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 244000309465 heifer Species 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000012543 microbiological analysis Methods 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000581835 Monodora junodii Species 0.000 description 1
- 241000580463 Nicrophorus Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000006160 differential media Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- -1 hydrogen ions Chemical class 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000021962 pH elevation Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/61—Propionibacterium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/807—Poultry or ruminant feed
Definitions
- the present invention relates generally to a process for improving the utilization of feedstuffs by ruminants, especially during the transition from a roughage diet to a feedlot diet, and more particularly to a process for administering to a ruminant a feed additive composition which includes Propionibacteria jensenii strain P-63, preferably in combination with a lactic acid producing bacteria for improving the production from, and feed conversion efficiency of, a high grain or concentrate feedlot diet.
- the composition also may be used to reduce scours in swine.
- Acute indigestion resulting from the transition from a predominantly roughage diet to a feedlot diet could be fatal to ruminants.
- the purpose of a feedlot operation is to fatten a ruminant, such as beef cattle, for sale or slaughter.
- the most common and efficient method of fattening ruminants is to feed them a high grain or high energy concentrate diet.
- this abrupt conversion from a roughage or pasture diet of plant food, mainly cellulose, to a feedlot diet predominantly composed of grains and starches can cause decreased production to feedlot cattle and even death from acidosis. Similar diet transitions can result in a decrease in milk production for dairy cows as well as death.
- the ruminal microflora ferment the new feed and produce 100 or more milli-moles per liter of lactic acid resulting in the rumen becoming immobilized.
- a large portion of the lactic acid accumulated may be the D( ⁇ ) isomer which is an unavailable energy source for the ruminant and thus builds up in the rumen.
- Absorption of the acid into the blood lowers the blood pH and diminishes the content of bicarbonate and glucose bringing about acidosis. Compensation for the acidic condition occurs by excretion of carbonic acid through rapid respiration and by excretion of hydrogen ions through urine. Affected cattle may survive through compensation, however, severe acidosis is fatal.
- the increase in acidity of the rumen damages the mucosa which may result in necrosis of the epithelium which enables bacteria such as Spherophorus necrophorus to enter the veins and be conveyed to the liver where liver abscesses may form in surviving animals.
- Lactic acid and products containing lactic acid have been found to enhance gains in the starting period of cattle (first 28 days) and reduce liver abscesses when given prior to the transition from a roughage diet to a feedlot diet.
- Various strains of Lactobacillus acidophilus have been isolated which restore and stabilize the internal microbial balance of animals.
- Manfredi et al, U.S. Pat. No. 4,980,164 is such a strain of Lactobacillus acidophilus which has been isolated for enhancing feed conversion efficiency.
- the Lactobacillus acidophilus strain of the Manfredi et al patent has been designated strain BT1386 and received accession number ATCC No. 53545 from the American Type Culture Collection in Rockville, Md.
- Strain ATCC 53545 demonstrates a greater propensity to adhere to the epithelial cells of some animals which would increase the bacteria cultures' ability to survive, initiate and maintain a population within an animal intestine.
- the primary mode of action as previously understood relative to Lactobacillus acidophilus occurs post-ruminally.
- Lactobacillus acidophilus isolated for restoring and stabilizing the internal microbial balance of animals is disclosed in Herman et al, U.S. Pat. No. 5,256,425.
- the Lactobacillus acidophilus strain of the Herman et al patent has been designated strain BT1389 and received accession number ATCC No. 55221 from the American Type Culture Collection in Rockville, Md.
- Strain ATCC 55221 is a further improvement on strain ATCC 53545 in that it is easily identified and quantified due to its resistance to antibiotics such as erythromycin and streptomycin.
- Lactobacillus acidophilus are perfectly good lactic acid producing organisms.
- more than a lactic acid producing organism is needed to improve the utilization of feedstuffs by ruminants, especially during the transition from a roughage diet to a feedlot diet.
- the problem with the increase of D-lactate in the rumen must also be resolved in order to facilitate the transition of ruminants from a roughage diet to a feedlot diet.
- U.S. Pat. Nos. 5,534,271 and 5,529,793 suggest that both a lactic acid producing culture as well as a lactate utilizing bacterial culture be combined with a typical animal feedlot diet to assist in the transition of a ruminant diet from roughage to feedlot while minimizing the risk of acidosis.
- These patents list several classes of materials from each of the producing and utilizing categories which may be selected for combination with the animal feedstock. Unfortunately, these patents do not give much guidance as to which of these specific cultures should be selected in order to gain efficacious results.
- lactate utilizing cultures which are specifically enabled by the examples are Propionibacterium P-5 , Propionibacterium P-42 and Propionibacterium P-99 and the only lactic acid producing cultures enabled by the examples are Lactobacillus acidophilus ATCC 53545 and Lactobacillus acidophilus strain LA45.
- the reference fails to disclose or suggest that amongst the thousands of permutations possible presented by their proposed combination of cultures, that synergistic results can occur by selecting a very specific strain of lactate utilizing culture not specifically enabled in these patents.
- the inventors of the instant invention have discovered such a specific lactate utilizing culture, namely Propionibacterium P-63.
- a novel direct fed microbial for ruminants having a specifically defined lactic acid utilizing culture which, when used alone as a direct fed microbial or combined with lactic acid producing cultures, can demonstrate unexpected results in terms of resistance against acidosis is provided.
- the lactic acid utilizing culture comprises Propionibacterium P-63. This increased resistance can enable the ruminant to be superior producers of milk, if dairy ruminants, or experience greater weight gain, if beef ruminants.
- This culture may also be used to reduce scours in swine.
- a first embodiment of the present, invention comprises a ruminant direct fed microbial composition of matter comprising an acidosis inhibiting effective amount of Propionibacterium P-63.
- the microbial composition is combined with an animal feed material selected from the group consisting of corn, dried grain, alfalfa, corn meal and mixtures thereof.
- the direct fed microbial composition further comprises a lactic acid producing bacterial culture, and even more preferably Lactobacillus acidophilus ATCC 53545.
- a second embodiment comprises a swine direct fed microbial composition of matter comprising a scour inhibiting effective amount of Propionibacterium P-63.
- Still another embodiment of the present invention comprises a process for reducing acidosis when converting a ruminant diet from a roughage diet to a grain diet by administering to a ruminant a direct fed microbial comprising an acidosis inhibiting effective amount of Propionibacterium P-63.
- the microbial composition is combined with an animal feed material selected from the group consisting of corn, dried grain, alfalfa, corn meal and mixtures thereof.
- Yet another embodiment comprises a process for reducing scours in swine by administering to a swine a direct fed microbial comprising an scour inhibiting effective amount of Propionibacterium P-63.
- the direct fed microbial composition further comprises a lactic acid producing bacterial culture for administration to the ruminant, and even more preferably Lactobacillus acidophilus ATCC 53545.
- An object of the present invention is to provide a novel direct fed microbial for ruminants or swine.
- Still another object of the present invention is to provide a process for reducing acidosis in ruminants when converting from a roughage diet to a grain diet.
- a further object of the present invention is to provide a synergistic combination of lactic acid producing cultures with lactate utilizing cultures to reduce acidosis in ruminants when converting from a roughage diet to a grain diet.
- Another object of the present invention is directed to a method for reducing scours in swine.
- Propionibacterium P-63 is a culture of the species propionibacterium jensenii , strain designation PJ54. This information is obtained from Communicable Disease Laboratory, in Atlanta, Ga., U.S.A. Genetic equivalents of this strain are expressly considered to be covered within the scope of the present invention.
- lactate utilizing bacteria in ruminant feeds, even those feeds designed to aid in the conversion of the ruminant from a roughage diet to a grain diet is not considered novel.
- the prior art is replete with listings of many genus/species and strains of materials suggested for ruminant feeds.
- Propionibacterium P-63 Prior to the present invention it is not believed that the use of Propionibacterium P-63 has been disclosed or suggested for use in animal feeds. The inventors have surprisingly discovered that this specific strain demonstrates superior anti-acidosis properties as compared to other lactate utilization bacteria.
- P-63 can be effectively used to treat scours in swine by administering a scour inhibiting amount of P-63 to a swine.
- the amount of Propionibacterium P-63 which should be administered to the animal ranges between about 1 ⁇ 10 6 cfu/animal/day to about 1 ⁇ 10 12 cfu/animal/day.
- Higher amounts of the bacterium are preferably used, i.e., greater than about 1 ⁇ 10 9 cfu/animal/day when the bacterium is the sole acidosis or scours control agent whereas lesser amounts, i.e., less than about 1 ⁇ 10 8 cfu/animal/day may be administered when a lactic acid producing bacterium culture is added in combination with the P-63.
- the bacterium culture may be administered to the ruminant in one of many ways.
- the culture can be administered in a solid form as a veterinary pharmaceutical, may be distributed in an excipient, preferably water, and directly fed to the animal, may be physically mixed with feed material in a dry form, or, in a most preferred embodiment, the culture may be formed into a solution and thereafter sprayed onto feed material.
- the method of administration of the culture to the animal is considered to be within the skill of the artisan.
- the feed material When used in combination with a feed material, the feed material is preferably grain based. Included amongst such feed materials are corn, dried grain, alfalfa, and corn meal and mixtures thereof.
- the bacteria cultures of the novel process may optionally be admixed with a dry formulation of additives including but not limited to growth substrates, enzymes, sugars, carbohydrates, extracts and growth promoting micro-ingredients.
- the sugars could include the following: lactose; maltose; dextrose; malto-dextrin; glucose; fructose; mannose; tagatose; sorbose; raffinose; and galactose.
- the sugars range from 50-95%, either individually or in combination.
- the extracts could include yeast or dried yeast fermentation solubles ranging from 5-50%.
- the growth substrates could include: trypticase, ranging from, 5-25%; sodium lactate, ranging from 5-30%; and, Tween 80, ranging from 1-5%.
- the carbohydrates could include mannitol, sorbitol, adonitol and arabitol. The carbohydrates range from 5-50% individually or in combination.
- the micro-ingredients could include the following: calcium carbonate, ranging from 0.5-5.0%; calcium chloride, ranging from 0.5-5.0%; dipotassium phosphate, ranging from 0.5-5.0%; calcium phosphate, ranging from 0.5-5.0%; manganese proteinate, ranging from 0.25-1.00%; and, manganese, ranging from 0.25-1.00%.
- the P-63 culture may be used alone in a method to prevent acidosis or scours, because of the high levels of administration required and the desire for even better resistance against disease, it is optionally combined with a lactic acid producing culture.
- a lactate producer in a beef direct fed microbial (DFM) to prevent/reduce acidosis. If the reason (or at least primary contributor) acidosis occurs is lactate production, adding a lactate producing organism with the DFM may likely be inconsequential. It is further hypothesized that a lactic acid producing culture may not be required when using P-63 to prevent scours in swine.
- DFM direct fed microbial
- the lactic acid producing bacteria could include, but is not limited to, the following: Lactobacillus acidophilus; Lactobacillus plantarum; Streptococcuus faecium; Lactobacillus casei; Lactobacillus lactis; Lactobacillus enterii; Lactobacillus fermentum; Lactobacillus delbruckii; Lactobacillus helveticus; Lactobacillus curvatus; Lactobacillus brevis; Lactobacillus bulgaricus; Lactobacillus cellobiosuus; Streptococcus lactis; Streptococcus thermophilus; Streptococcus cremoris; Streptococcus diacetylactis; Streptococcus intermedius; Bifidobacterium animalis; Bifidobacterium adolescentis; Bifidobacterium bifidum; Bifidobacterium infantis; B
- the amount of lactic acid producing culture which should be administered to the animal ranges between about 1 ⁇ 10 6 cfu/animal/day to about 1 ⁇ 10 12 cfu/animal/day, with amounts ranging from about 1 ⁇ 10 7 cfu/animal/day to about 1 ⁇ 10 9 cfu/animal/day being most preferred.
- Propionibacterium cultures used in this study are obtained from the culture collection of Agtech Products, Inc., Waukesha, Wis. Cultures are maintained at ⁇ 75° C. in a sodium lactate broth (NLB) supplemented with 10% glycerol (Hofherr and Glatz, 1983). The specific propionibacteria strains used in this study are listed in Table 1.
- the acidified medium is prepared by including 80 mM L(+) lactic acid in a basal broth containing 1% yeast extract, 1% tryptone, dipotassium phosphate and distilled water.
- the pH of the broth medium is raised to pH 5.0 using 5.0 M NaOH.
- filter sterilization Gibcos Chemical Sciences, Ann Arbor, Mich.
- Neutralized broth medium is prepared the same as acidified media except that the pH of broth is raised to 7.0 with 5.0 M NaOH prior to filter sterilization.
- Rumen fluid simulation medium Ruminal fluid is collected via ruminal cannula 2 h post feeding from a cross-bred beef heifer fed a high roughage diet.
- the ruminal fluid is strained through four layers of cheesecloth and transported to the laboratory in an insulated container.
- Test ruminal fluid media contains 250 ml of strained ruminal fluid, 62.5 ml McDougall's buffer (McDougall, 1948), and 1.5% dextrose.
- the added dextrose serves as a readily fermented carbohydrate to simulate conditions found in the rumen of animals following grain engorgement.
- Strained ruminal fluid, buffer, and dextrose are dispensed into sterilized 500 ml bottles and allowed to equilibrate in a water bath at 39° C. for approximately 15 minutes prior to inoculation.
- Initial pH of the rumen fluid model ranged from 6.6 to 6.9 depending on date of collection.
- Samples are prepared for HPLC analysis by aseptically removing 1.0 ml from the test medium at the appropriate sampling times. Samples are placed in a 1.5 ml microcentrifuge tube and the cells are pelleted by centrifugation (10 minutes, at 12,500 rpm). A sample of the supernatant fluid (0.5 ml) is transferred to a clean tube and acidified with an equal volume of 0.01 M sulfuric acid solution to stop fermentation. These samples are stored at ⁇ 20° C. until analysis is performed. For analysis, frozen tubes are allowed to thaw at room temperature and filtered through 0.2 um filters directly into 2 ml HPLC autosampler vials and capped.
- Samples are analyzed using a Hewlett Packard 1090 HPLC system equipped with a diode-array detector (Hewlett Packard, Atlanta, Ga.).
- the sample is injected into 0.005 M H 2 SO 4 mobile phase heated to 65° C. and separated using a BioRad HPX-87H column (Bio-Rad Laboratories, Inc., Hercules, Calif.).
- the peaks are detected with a diode array detector at 210 nm. Other wavelengths are recorded and examined for peak purity, but 210 nm is the optimum setting for determining peak height with minimum background noise. Peak areas are used to determine compound concentrations by comparison with external standards. Peak purity is monitored by UV scanning techniques as an aid in identifying abnormal wavelength patterns present in a single peak.
- Rumen model experimental procedures Duplicate bottles are inoculated with the appropriate propionibacteria strain to be tested at a level of 1 ⁇ 10 7 cfu/ml. Bottles are flushed with CO 2 , capped, and incubated at 39° C. for 48 h. Every 6 h during the 48 h incubation period, samples are collected and analyzed for pH, lactic acid and volatile fatty acid (VFA) concentrations. Additional samples are collected at 16 h and 48 h for use in microbiological analysis. Lactic acid and VFA samples are prepared by aseptically collecting a 1 ml sample in a 1.5 ml microcentrifuge tube. Cells are pelleted by centrifugation (10 minutes at 12,500 ⁇ g). One-half ml of supernatant is mixed with an equal volume of 10 mM H 2 SO 4 and filtered through a 0.2 um membrane filter.
- Microbiological analysis consists of plating serial dilutions (10 ⁇ 3 , 10 ⁇ 4 and 10 ⁇ 5 ) of the in vitro rumen fluid medium on a propionibacteria selective-differential medium (PSA). Colonies with typical propionibacteria morphology are confirmed using pulsed-field gel electrophoresis (PFGE).
- PSA propionibacteria selective-differential medium
- P42 has the highest rate of pH increase (0.0377 units/h), but is not statistically (P ⁇ 0.05) different from strains P63, P54, P25, and P41. Strain P42 also has the highest rate of lactic acid utilization (1.61 mM/h) compared to others but is not statistically (p ⁇ 0.05) different from strains P63, P54, P25, P41, P111, P81, and P104. Since linear regression analysis does not adjust for differences in lag times, other non-linear methods were employed
- Ruminal fluid simulation data is analyzed using the Gompertz non-linear equation technique. Values up to 24 h are used in the analysis since a decrease in lactic acid concentration is observed after 24 h in all controls. Flasks inoculated with strains P54 and P63 have significantly lower rates of hydrogen ion accumulation (Table 3).
- Lactate H+ increase Time lag of lactate Time lag production rate production of H+ Strain rate (mM/h) ( ⁇ 10 ⁇ 5 ) (h) increase (h) P25 18.87 4.65 4.41+ 4.20 P31 38.85 11.63 5.15 3.81 P41 23.31 11.15 4.65 3.29 P42 24.42 7.46 5.52 3.99 P48 38.85 1.45 5.45 3.27 P49 6.67 6.45 5.89 3.28 P54 21.09 ⁇ 1.45** 8.08** 3.56 P63 9.99 2.18* 6.47+ 2.68 P78 12.21 9.34 5.30 3.02 P81 1.11 9.86 4.91 2.99 P88 14.43 11.49 5.76 2.87 P89 9.99 13.57 5.71 3.13 P90 14.43 5.18 5.00 3.28 P99 4.44 7.87 4.94 3.59 P104 ⁇ 2.22 8.02 4.94 2.67 P111 14.43 5.17 4.97 5.74* Control
- strains P54 and P63 have significantly different values of ⁇ 1.45 and 2.18 respectively.
- Strains P54, P63 and also P25 have a significant impact on the lactic acid production lag time.
- P54 and P63 increase the lag time of lactic acid accumulation by 2.06 and 2.63 (h) respectively, thereby slowing the accumulation of acid.
- strain P25 decreases the lag time of inoculated samples thus resulting in faster lactic acid accumulation.
- Strain P111 is the only strain found to significantly increase the lag time of H + .
- the viable plate counts of strains at 16 h and 48 h of incubation in the rumen simulation model are present in Table 4.
- Nine strains maintain a population of at least 1.0 ⁇ 10 4 cfu/ml for 48 hours.
- Six of the nine strains exceed 1.0 ⁇ 10 5 cfu/ml; strains P25 and P63 have the highest rates of survival at 6.0 ⁇ 10 5 and 1.0 ⁇ 10 6 cfu/ml, respectively.
- Each treatment group consisting of steers and heifers are fed a 50:50 ration (cracked corn, cottonseed meal, alfalfa pellets and balanced for minerals) at 1.5 to 2% of BW for 14 days. During this period the appropriate treatment is added directly to the feed.
- the treatment dose for each individual pen is added to 600 ml of water and completely mixed with the daily ration at the time of feeding throughout the entire feeding study.
- cattle do not receive any feed for a 24 h period. This procedure is performed in order to stimulate the engorgement of the next meal. Following the 24 hour fasting period, cattle are given a 90% concentration ration (75% cracked wheat and 25% cracked corn). This ration is fed for a total of 10 days. During this time, treatments are administered as stated above and cattle are closely monitored for signs of severe stress due to ruminal indigestion. Following the 10 day challenge period, cattle are fed a 90% concentrate diet consisting of 100% cracked corn. Cattle are fed to final weights of approximately 1,200 pounds (approx. 120 days).
- cattle All cattle are weighed at receiving and approximately every 28 days during the feeding period. Feed intake and animal health are monitored daily. Following the finishing period, cattle are transported to a packing plant at which time hot carcass weights, quality grades, yield grades, and carcass characteristics were determined.
- Feeding intake is reduced in cattle being fed the combination inoculum by 7.8% when compared to control animals during the first 83 days (p ⁇ 0.02). Overall feed intake is 6.8% lower for the combination treatment (P ⁇ 0.08) and only 2.8% lower when animals received P63 alone (not significant) when compared to controls.
- Average daily gains are slightly higher for cattle fed the combination during the first and last 30 days of the study. However, these differences are not significant. Cattle receiving P63 alone have slightly lower gains compared to control and cattle fed the combination inoculum during the entire study. Overall average daily gain (ADG) is almost identical during the 120 day feeding period.
- Cattle which is fed the combination inoculum has significantly improved feed efficiencies over the entire 120 day feeding study when compared to controls. During the first 10 days of feeding, efficiency is improved by 38.4% (P ⁇ 0.06) and by 10.4% (P ⁇ 03) in the first 30 days when comparing cattle fed the combination to control cattle. The percent difference between treatments declines in the later periods of the feeding trial, however the significant treatment response of the combination inoculum during the initial period results in a significant treatment difference over the entire 120 day study (P ⁇ 0.04).
- liver abscesses are relatively insignificant as compared to industry standards. Control and cattle fed P63 both have incidences of 8%. Cattle fed Lactobacillus acidophilus strain 53545 with Propionibacterium strain P63 have no liver abscesses. Generally, feedlot finished cattle will have a liver incidence of approximately 30%. Dressing percents, ribeye area, yield grades, and quality grades are similar for all treatments.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Animal Husbandry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Fodder In General (AREA)
Abstract
A ruminant direct fed microbial composition of matter comprising an acidosis inhibiting effective amount of Propionibacterium P-63 is provided. Also disclosed is a process for reducing acidosis in ruminants or scours in swine by administration of the bacterium to the ruminant or swine. The microbial composition may be administered by itself, or combined with animal feed and/or lactic acid producing cultures.
Description
This application is a divisional of application Ser. No. 09/292,720 filed on Apr. 15, 1999 now U.S. Pat. No. 6,455,063.
This application claims the benefit of Provisional Application No. 60/082,067 filed Apr. 17, 1998.
1. Field of the Invention
The present invention relates generally to a process for improving the utilization of feedstuffs by ruminants, especially during the transition from a roughage diet to a feedlot diet, and more particularly to a process for administering to a ruminant a feed additive composition which includes Propionibacteria jensenii strain P-63, preferably in combination with a lactic acid producing bacteria for improving the production from, and feed conversion efficiency of, a high grain or concentrate feedlot diet. The composition also may be used to reduce scours in swine.
2. Technology Description
Acute indigestion resulting from the transition from a predominantly roughage diet to a feedlot diet could be fatal to ruminants. The purpose of a feedlot operation is to fatten a ruminant, such as beef cattle, for sale or slaughter. The most common and efficient method of fattening ruminants is to feed them a high grain or high energy concentrate diet. However, this abrupt conversion from a roughage or pasture diet of plant food, mainly cellulose, to a feedlot diet predominantly composed of grains and starches can cause decreased production to feedlot cattle and even death from acidosis. Similar diet transitions can result in a decrease in milk production for dairy cows as well as death.
As discussed in Diseases of Feedlot Cattle, Second Edition, Lea & Febiger, p 292-293 (1971), acute indigestion in cattle is caused by sudden consumption of large amounts of grain, green corn, green apples or other easily fermentable feeds. During a roughage diet, cellulosic bacteria predominates in ruminal microflora. Volatile fatty acids are usually formed in the following proportions: acetic, 67%; propionic, 19%; and butyric, 14%. These acids constitute an important nutrient from cellulose digestion. However, during the fattening process at the feedlot, cattle are placed on a high grain diet. On a high grain diet, the ruminal microflora ferment the new feed and produce 100 or more milli-moles per liter of lactic acid resulting in the rumen becoming immobilized. A large portion of the lactic acid accumulated may be the D(−) isomer which is an unavailable energy source for the ruminant and thus builds up in the rumen. Absorption of the acid into the blood lowers the blood pH and diminishes the content of bicarbonate and glucose bringing about acidosis. Compensation for the acidic condition occurs by excretion of carbonic acid through rapid respiration and by excretion of hydrogen ions through urine. Affected cattle may survive through compensation, however, severe acidosis is fatal. Additionally, the increase in acidity of the rumen damages the mucosa which may result in necrosis of the epithelium which enables bacteria such as Spherophorus necrophorus to enter the veins and be conveyed to the liver where liver abscesses may form in surviving animals.
Lactic acid and products containing lactic acid have been found to enhance gains in the starting period of cattle (first 28 days) and reduce liver abscesses when given prior to the transition from a roughage diet to a feedlot diet. Various strains of Lactobacillus acidophilus have been isolated which restore and stabilize the internal microbial balance of animals. Manfredi et al, U.S. Pat. No. 4,980,164, is such a strain of Lactobacillus acidophilus which has been isolated for enhancing feed conversion efficiency. The Lactobacillus acidophilus strain of the Manfredi et al patent has been designated strain BT1386 and received accession number ATCC No. 53545 from the American Type Culture Collection in Rockville, Md. Strain ATCC 53545 demonstrates a greater propensity to adhere to the epithelial cells of some animals which would increase the bacteria cultures' ability to survive, initiate and maintain a population within an animal intestine. Thus, the primary mode of action as previously understood relative to Lactobacillus acidophilus occurs post-ruminally.
Another strain of Lactobacillus acidophilus isolated for restoring and stabilizing the internal microbial balance of animals is disclosed in Herman et al, U.S. Pat. No. 5,256,425. The Lactobacillus acidophilus strain of the Herman et al patent has been designated strain BT1389 and received accession number ATCC No. 55221 from the American Type Culture Collection in Rockville, Md. Strain ATCC 55221 is a further improvement on strain ATCC 53545 in that it is easily identified and quantified due to its resistance to antibiotics such as erythromycin and streptomycin.
The above-mentioned strains of Lactobacillus acidophilus are perfectly good lactic acid producing organisms. However, more than a lactic acid producing organism is needed to improve the utilization of feedstuffs by ruminants, especially during the transition from a roughage diet to a feedlot diet. The problem with the increase of D-lactate in the rumen must also be resolved in order to facilitate the transition of ruminants from a roughage diet to a feedlot diet.
Administration of bacteria to cattle is also problem due to the extreme sensitivity of organisms like Lactobacillus acidophilus which are difficult to maintain in a viable state at ambient temperatures. Also, lactic acid is corrosive to feedlot and feedmill equipment and metallic components
U.S. Pat. Nos. 5,534,271 and 5,529,793 suggest that both a lactic acid producing culture as well as a lactate utilizing bacterial culture be combined with a typical animal feedlot diet to assist in the transition of a ruminant diet from roughage to feedlot while minimizing the risk of acidosis. These patents list several classes of materials from each of the producing and utilizing categories which may be selected for combination with the animal feedstock. Unfortunately, these patents do not give much guidance as to which of these specific cultures should be selected in order to gain efficacious results. The only lactate utilizing cultures which are specifically enabled by the examples are Propionibacterium P-5, Propionibacterium P-42 and Propionibacterium P-99 and the only lactic acid producing cultures enabled by the examples are Lactobacillus acidophilus ATCC 53545 and Lactobacillus acidophilus strain LA45. The reference fails to disclose or suggest that amongst the thousands of permutations possible presented by their proposed combination of cultures, that synergistic results can occur by selecting a very specific strain of lactate utilizing culture not specifically enabled in these patents. The inventors of the instant invention have discovered such a specific lactate utilizing culture, namely Propionibacterium P-63.
Despite the above teachings, there still exists a need in the art for a direct fed microbial for ruminants having a specifically defined lactic acid utilizing culture which, when combined with lactic acid producing cultures, can demonstrate unexpected results in terms of efficacy against acidosis.
In addition, there exists a need in the art for a direct fed microbial which may reduce scours in swine and companion animals as the above technology has been more specifically directed against treatment of acidosis in ruminants.
In accordance with the present invention a novel direct fed microbial for ruminants having a specifically defined lactic acid utilizing culture which, when used alone as a direct fed microbial or combined with lactic acid producing cultures, can demonstrate unexpected results in terms of resistance against acidosis is provided. More specifically, the lactic acid utilizing culture comprises Propionibacterium P-63. This increased resistance can enable the ruminant to be superior producers of milk, if dairy ruminants, or experience greater weight gain, if beef ruminants. This culture may also be used to reduce scours in swine.
A first embodiment of the present, invention comprises a ruminant direct fed microbial composition of matter comprising an acidosis inhibiting effective amount of Propionibacterium P-63. In most embodiments, the microbial composition is combined with an animal feed material selected from the group consisting of corn, dried grain, alfalfa, corn meal and mixtures thereof.
In the preferred embodiment, the direct fed microbial composition further comprises a lactic acid producing bacterial culture, and even more preferably Lactobacillus acidophilus ATCC 53545.
A second embodiment comprises a swine direct fed microbial composition of matter comprising a scour inhibiting effective amount of Propionibacterium P-63.
Still another embodiment of the present invention comprises a process for reducing acidosis when converting a ruminant diet from a roughage diet to a grain diet by administering to a ruminant a direct fed microbial comprising an acidosis inhibiting effective amount of Propionibacterium P-63.
In most embodiments, the microbial composition is combined with an animal feed material selected from the group consisting of corn, dried grain, alfalfa, corn meal and mixtures thereof.
Yet another embodiment comprises a process for reducing scours in swine by administering to a swine a direct fed microbial comprising an scour inhibiting effective amount of Propionibacterium P-63.
In a preferred embodiment, the direct fed microbial composition further comprises a lactic acid producing bacterial culture for administration to the ruminant, and even more preferably Lactobacillus acidophilus ATCC 53545.
An object of the present invention is to provide a novel direct fed microbial for ruminants or swine.
Still another object of the present invention is to provide a process for reducing acidosis in ruminants when converting from a roughage diet to a grain diet.
A further object of the present invention is to provide a synergistic combination of lactic acid producing cultures with lactate utilizing cultures to reduce acidosis in ruminants when converting from a roughage diet to a grain diet.
Another object of the present invention is directed to a method for reducing scours in swine.
These, and other objects, will readily be apparent to those skilled in the art as reference is made to the detailed description of the preferred embodiment.
In describing the preferred embodiment, certain terminology will be utilized for the sake of clarity. Such terminology is intended to encompass the recited embodiment, as well as all technical equivalents which operate in a similar manner for a similar purpose to achieve a similar result.
Propionibacterium P-63 is a culture of the species propionibacterium jensenii, strain designation PJ54. This information is obtained from Communicable Disease Laboratory, in Atlanta, Ga., U.S.A. Genetic equivalents of this strain are expressly considered to be covered within the scope of the present invention.
The use of lactate utilizing bacteria in ruminant feeds, even those feeds designed to aid in the conversion of the ruminant from a roughage diet to a grain diet is not considered novel. The prior art is replete with listings of many genus/species and strains of materials suggested for ruminant feeds. Prior to the present invention it is not believed that the use of Propionibacterium P-63 has been disclosed or suggested for use in animal feeds. The inventors have surprisingly discovered that this specific strain demonstrates superior anti-acidosis properties as compared to other lactate utilization bacteria. While not wishing to be bound to any specific scientific theory, use of this strain of bacteria during conversion of the ruminant feed from a roughage diet to a feedlot diet does not result in an appreciable production of lactic acid in the rumen, allowing it to remain at a relatively constant pH.
It is also believed that P-63 can be effectively used to treat scours in swine by administering a scour inhibiting amount of P-63 to a swine.
In practice, the amount of Propionibacterium P-63 which should be administered to the animal ranges between about 1×106 cfu/animal/day to about 1×1012 cfu/animal/day. Higher amounts of the bacterium are preferably used, i.e., greater than about 1×109 cfu/animal/day when the bacterium is the sole acidosis or scours control agent whereas lesser amounts, i.e., less than about 1×108 cfu/animal/day may be administered when a lactic acid producing bacterium culture is added in combination with the P-63.
The bacterium culture may be administered to the ruminant in one of many ways. The culture can be administered in a solid form as a veterinary pharmaceutical, may be distributed in an excipient, preferably water, and directly fed to the animal, may be physically mixed with feed material in a dry form, or, in a most preferred embodiment, the culture may be formed into a solution and thereafter sprayed onto feed material. The method of administration of the culture to the animal is considered to be within the skill of the artisan.
When used in combination with a feed material, the feed material is preferably grain based. Included amongst such feed materials are corn, dried grain, alfalfa, and corn meal and mixtures thereof.
The bacteria cultures of the novel process may optionally be admixed with a dry formulation of additives including but not limited to growth substrates, enzymes, sugars, carbohydrates, extracts and growth promoting micro-ingredients. The sugars could include the following: lactose; maltose; dextrose; malto-dextrin; glucose; fructose; mannose; tagatose; sorbose; raffinose; and galactose. The sugars range from 50-95%, either individually or in combination. The extracts could include yeast or dried yeast fermentation solubles ranging from 5-50%. The growth substrates could include: trypticase, ranging from, 5-25%; sodium lactate, ranging from 5-30%; and, Tween 80, ranging from 1-5%. The carbohydrates could include mannitol, sorbitol, adonitol and arabitol. The carbohydrates range from 5-50% individually or in combination. The micro-ingredients could include the following: calcium carbonate, ranging from 0.5-5.0%; calcium chloride, ranging from 0.5-5.0%; dipotassium phosphate, ranging from 0.5-5.0%; calcium phosphate, ranging from 0.5-5.0%; manganese proteinate, ranging from 0.25-1.00%; and, manganese, ranging from 0.25-1.00%.
While the P-63 culture may be used alone in a method to prevent acidosis or scours, because of the high levels of administration required and the desire for even better resistance against disease, it is optionally combined with a lactic acid producing culture. Despite the above, it is hypothesized that one does not need a lactate producer in a beef direct fed microbial (DFM) to prevent/reduce acidosis. If the reason (or at least primary contributor) acidosis occurs is lactate production, adding a lactate producing organism with the DFM may likely be inconsequential. It is further hypothesized that a lactic acid producing culture may not be required when using P-63 to prevent scours in swine.
If added, the lactic acid producing bacteria could include, but is not limited to, the following: Lactobacillus acidophilus; Lactobacillus plantarum; Streptococcuus faecium; Lactobacillus casei; Lactobacillus lactis; Lactobacillus enterii; Lactobacillus fermentum; Lactobacillus delbruckii; Lactobacillus helveticus; Lactobacillus curvatus; Lactobacillus brevis; Lactobacillus bulgaricus; Lactobacillus cellobiosuus; Streptococcus lactis; Streptococcus thermophilus; Streptococcus cremoris; Streptococcus diacetylactis; Streptococcus intermedius; Bifidobacterium animalis; Bifidobacterium adolescentis; Bifidobacterium bifidum; Bifidobacterium infantis; Bifidobacterium longum; Bifidobacterium thermephilum; Pediococcus acidilactici; and, Pediococcus pentosaceus. Particularly preferred is the use of Lactobacillus acidophilus, and most preferably the strain corresponding to ATCC 53545.
When a lactic acid producing culture is utilized in combination with P-63, In practice, the amount of lactic acid producing culture which should be administered to the animal ranges between about 1×106 cfu/animal/day to about 1×1012 cfu/animal/day, with amounts ranging from about 1×107 cfu/animal/day to about 1×109 cfu/animal/day being most preferred.
The invention is described in greater detail by the following non-limiting examples.
Bacterial Strains.
Propionibacterium cultures used in this study are obtained from the culture collection of Agtech Products, Inc., Waukesha, Wis. Cultures are maintained at −75° C. in a sodium lactate broth (NLB) supplemented with 10% glycerol (Hofherr and Glatz, 1983). The specific propionibacteria strains used in this study are listed in Table 1.
TABLE 1 |
Propionibacterium strains |
Strain number | Species designation | Strain designation | Source |
P2 | P. acidipropionici | 128 | B |
P3 | P. acidipropionici | E14 | A |
P4 | P. thoenii | TH25 | A |
P5 | P. acidipropionici | E214 | A |
P9 | P. acidipropionici | 129 | B |
P10 | P. thoenii | R9611 | A |
P15 | P. thoenii | TH20 | A |
P20 | P. thoenii | TH21 | A |
P21 | P. thoenii | R6 | A |
P25 | P. jensenii | J17 | A |
P26 | P. thoenii | 8266 | B |
P31 | P. freudenreichii | 1294 | E |
P35 | P. acidipropionici | 1505 | E |
P38 | P. acidipropionici | 13 | D |
P41 | P. jensenii | 14 | D |
P42 | P. acidipropionici | 10 | D |
P44 | P. jensenii | 363 | E |
P46 | P. jensenii | E.1.2 | F |
P48 | P. freudenreichii | E.11.3 | F |
P49 | P. freudenreichii | E.15.01 | F |
P50 | P. acidipropionici | E.7.1 | F |
P52 | P. acidipropionici | E.5.1 | F |
P53 | P. acidipropionici | E.5.2 | F |
P54 | P. jensenii | E.1.1 | F |
P63 | P. jensenii | PJ54 | G |
P68 | P. jensenii | PJ53 | G |
P69 | P. jensenii | PJ23 | G |
P74 | P. jensenii | PZ99 | G |
P78 | P. acidipropionici | PA62 | G |
P79 | P. thoenii | PT52 | G |
P81 | P. acidipropionici | PP798 | G |
P85 | P. thoenii | 20 | H |
P86 | P. jensenii | 11 | H |
P88 | P. jensenii | 22 | H |
P89 | P. freudenreichii | 5571 | I |
P90 | P. acidipropionici | 5578 | I |
P96 | P. freudenreichii | 8903 | I |
P99 | P. freudenreichii | ATCC 9615 | J |
P101 | P. freudenreichii | ATCC 9617 | J |
P104 | P. freudenreichii | ATCC 6207 | J |
P105 | P. thoenii | ATCC 4871 | J |
P106 | P. jensenii | ATCC 4964 | J |
P108 | P. acidipropionici | ATCC 14072 | J |
P111 | P. acidipropionici | O | |
Sources: (A) Cornell University, Ithaca, NY; (B) Iowa State University, Ames IA; (C) Dr. K W Sahli, Station Federale D'Industrie Laitiere Liebefeld-Bern, Switzerland; (D) Dr. W. Kundrat, University of Munich, Munich, Germany; (E). Dr. V. B. D. Skerman, University of Queensland, Brisbane, Australia; (F) Dr. C. B. van Neil, Hopkins Marine Station, Pacific Grove, CA; (G) Communicable Disease Laboratory, Atlanta, GA, (H) Isolated from Gruyere cheese imported from France, (J) American | |||
# Type Culture Collection, Rockville, MD; (O). Origin unknown. |
Culture conditions. Strains are activated by placing a portion of the frozen suspension in 10 ml of NLB and incubating at 32° C. for 36-48 hours. Strains are sub-cultured by transferring a 1% volume of the culture at mid-log growth to fresh NLB. Cultures are transferred a minimum of three times before being tested. The purity of tested strains is monitored by regularly streaking cultures onto a sodium lactate agar (NLA).
In vitro acidified and neutralized broth medium. Primary strain selection involves testing the growth and lactic acid utilization of cultures in a basal broth media. The acidified medium is prepared by including 80 mM L(+) lactic acid in a basal broth containing 1% yeast extract, 1% tryptone, dipotassium phosphate and distilled water. The pH of the broth medium is raised to pH 5.0 using 5.0 M NaOH. Following filter sterilization (Gelman Sciences, Ann Arbor, Mich.), the medium is dispensed at a volume of 10 ml into sterile screw cap test tubes. Neutralized broth medium is prepared the same as acidified media except that the pH of broth is raised to 7.0 with 5.0 M NaOH prior to filter sterilization.
Rumen fluid simulation medium. Ruminal fluid is collected via ruminal cannula 2 h post feeding from a cross-bred beef heifer fed a high roughage diet. The ruminal fluid is strained through four layers of cheesecloth and transported to the laboratory in an insulated container. Test ruminal fluid media contains 250 ml of strained ruminal fluid, 62.5 ml McDougall's buffer (McDougall, 1948), and 1.5% dextrose. The added dextrose serves as a readily fermented carbohydrate to simulate conditions found in the rumen of animals following grain engorgement. Strained ruminal fluid, buffer, and dextrose are dispensed into sterilized 500 ml bottles and allowed to equilibrate in a water bath at 39° C. for approximately 15 minutes prior to inoculation. Initial pH of the rumen fluid model ranged from 6.6 to 6.9 depending on date of collection.
High pressure liquid chromatography. Samples are prepared for HPLC analysis by aseptically removing 1.0 ml from the test medium at the appropriate sampling times. Samples are placed in a 1.5 ml microcentrifuge tube and the cells are pelleted by centrifugation (10 minutes, at 12,500 rpm). A sample of the supernatant fluid (0.5 ml) is transferred to a clean tube and acidified with an equal volume of 0.01 M sulfuric acid solution to stop fermentation. These samples are stored at −20° C. until analysis is performed. For analysis, frozen tubes are allowed to thaw at room temperature and filtered through 0.2 um filters directly into 2 ml HPLC autosampler vials and capped.
Samples are analyzed using a Hewlett Packard 1090 HPLC system equipped with a diode-array detector (Hewlett Packard, Atlanta, Ga.). The sample is injected into 0.005 M H2SO4 mobile phase heated to 65° C. and separated using a BioRad HPX-87H column (Bio-Rad Laboratories, Inc., Hercules, Calif.). The peaks are detected with a diode array detector at 210 nm. Other wavelengths are recorded and examined for peak purity, but 210 nm is the optimum setting for determining peak height with minimum background noise. Peak areas are used to determine compound concentrations by comparison with external standards. Peak purity is monitored by UV scanning techniques as an aid in identifying abnormal wavelength patterns present in a single peak.
Rumen model experimental procedures. Duplicate bottles are inoculated with the appropriate propionibacteria strain to be tested at a level of 1×107 cfu/ml. Bottles are flushed with CO2, capped, and incubated at 39° C. for 48 h. Every 6 h during the 48 h incubation period, samples are collected and analyzed for pH, lactic acid and volatile fatty acid (VFA) concentrations. Additional samples are collected at 16 h and 48 h for use in microbiological analysis. Lactic acid and VFA samples are prepared by aseptically collecting a 1 ml sample in a 1.5 ml microcentrifuge tube. Cells are pelleted by centrifugation (10 minutes at 12,500× g). One-half ml of supernatant is mixed with an equal volume of 10 mM H2SO4 and filtered through a 0.2 um membrane filter.
Microbiological analysis consists of plating serial dilutions (10−3, 10−4 and 10−5) of the in vitro rumen fluid medium on a propionibacteria selective-differential medium (PSA). Colonies with typical propionibacteria morphology are confirmed using pulsed-field gel electrophoresis (PFGE).
Differences in pH and lactic acid concentration between inoculated and uninoculated controls at each sampling time are calculated and regressed against incubation time up to 24 h in order to select the best lactic acid utilizing strains. Strains for which a change over time in lactate or pH was detected (an R>0.50 against sampling time) are compared using Duncan's Multiple Range procedures (SAS, 1985). Additionally, Gompertz equation is used to analyze the sigmoidal curves for pH decrease and lactic acid concentration increase (Zwietering et al. 1990).
Results. The rate of change in pH and lactic acid concentration is determined by regressing the difference between inoculated and control rumen fluid incubations against time. Only when the regression coefficient for rate of change in pH and lactate was greater than 0.50 for an inoculated flask was the data, included in the statistical analysis (Table 2).
TABLE 2 |
Impact of added Propionibacterium strains on rates of change in |
pH and lactate concentration of incubated rumen fluid models. |
Strain | pH elevation, (Units/h) | Lactate decrease (mM/h) |
42 | .03770 | 1.61 |
63 | .03627 | 1.30 |
54 | .02433 | 1.26 |
25 | .02380 | 1.12 |
41 | .02372 | 1.55 |
111 | .01691 | 1.05 |
81 | .01064 | .71 |
104 | .00923 | .88 |
89 | .00785 | .53 |
88 | .00590 | .76 |
49 | .00425 | .65 |
48 | .00366 | NA |
99 | .00051 | −.17 |
31 | .00026 | −.22 |
90 | −.00917 | −.32 |
Calculated by regressing the difference between inoculated and control fluid against incubation time. | ||
Means in a column with the same superscript are not different (P < .05). |
Compared with other strains, P42 has the highest rate of pH increase (0.0377 units/h), but is not statistically (P<0.05) different from strains P63, P54, P25, and P41. Strain P42 also has the highest rate of lactic acid utilization (1.61 mM/h) compared to others but is not statistically (p<0.05) different from strains P63, P54, P25, P41, P111, P81, and P104. Since linear regression analysis does not adjust for differences in lag times, other non-linear methods were employed
Ruminal fluid simulation data is analyzed using the Gompertz non-linear equation technique. Values up to 24 h are used in the analysis since a decrease in lactic acid concentration is observed after 24 h in all controls. Flasks inoculated with strains P54 and P63 have significantly lower rates of hydrogen ion accumulation (Table 3).
TABLE 3 |
Contrasts of maximum lactate accumulation and minimum pH of |
rumen models inoculated with various propionibacteria strains. |
Lactate | H+ increase | Time lag of lactate | Time lag | |
production | rate | production | of H+ | |
Strain | rate (mM/h) | (× 10−5) | (h) | increase (h) |
P25 | 18.87 | 4.65 | 4.41+ | 4.20 |
P31 | 38.85 | 11.63 | 5.15 | 3.81 |
P41 | 23.31 | 11.15 | 4.65 | 3.29 |
P42 | 24.42 | 7.46 | 5.52 | 3.99 |
P48 | 38.85 | 1.45 | 5.45 | 3.27 |
P49 | 6.67 | 6.45 | 5.89 | 3.28 |
P54 | 21.09 | −1.45** | 8.08** | 3.56 |
P63 | 9.99 | 2.18* | 6.47+ | 2.68 |
P78 | 12.21 | 9.34 | 5.30 | 3.02 |
P81 | 1.11 | 9.86 | 4.91 | 2.99 |
P88 | 14.43 | 11.49 | 5.76 | 2.87 |
P89 | 9.99 | 13.57 | 5.71 | 3.13 |
P90 | 14.43 | 5.18 | 5.00 | 3.28 |
P99 | 4.44 | 7.87 | 4.94 | 3.59 |
P104 | −2.22 | 8.02 | 4.94 | 2.67 |
P111 | 14.43 | 5.17 | 4.97 | 5.74* |
Control | 38.85 | 17.99 | 5.45 | 4.72 |
*Values significantly different when compared to controls (P < 05) | ||||
+Values significantly different when compared to controls (P < .01) | ||||
**Values significantly different when compared to controls (P < .001) |
When the rate of H+ increase of inoculated flasks is compared to the control (0.00018), only strains P54 and P63 have significantly different values of −1.45 and 2.18 respectively. Strains P54, P63 and also P25 have a significant impact on the lactic acid production lag time. P54 and P63 increase the lag time of lactic acid accumulation by 2.06 and 2.63 (h) respectively, thereby slowing the accumulation of acid. On the other hand, strain P25 decreases the lag time of inoculated samples thus resulting in faster lactic acid accumulation. Strain P111 is the only strain found to significantly increase the lag time of H+.
The viable plate counts of strains at 16 h and 48 h of incubation in the rumen simulation model are present in Table 4. Nine strains maintain a population of at least 1.0×104 cfu/ml for 48 hours. Six of the nine strains exceed 1.0×105 cfu/ml; strains P25 and P63 have the highest rates of survival at 6.0×105 and 1.0×106 cfu/ml, respectively.
TABLE 4 |
Survival of Propionibacterium strains in the |
rumen model after 16 and 48 hours of incubation.* |
Propionibacterium (cfu/ml) |
Strain | 16 h | 48 h |
63 | 7.4 × 106 | 1.0 × 106 |
25 | 2.5 × 105 | 6.0 × 105 |
81 | 5.0 × 106 | 3.0 × 105 |
90 | 1.0 × 104 | 1.0 × 105 |
88 | 8.3 × 106 | 1.0 × 105 |
54 | 1.0 × 105 | 1.0 × 105 |
111 | 2.0 × 106 | 1.0 × 104 |
99 | 1.0 × 104 | 1.0 × 104 |
41 | 4.7 × 106 | 1.0 × 104 |
104 | 5.0 × 106 | 1.0 × 103 |
89 | 1.0 × 103 | 1.0 × 103 |
48 | 1.0 × 105 | 1.0 × 103 |
42 | 1.1 × 106 | 1.0 × 103 |
31 | 1.0 × 103 | 1.0 × 103 |
*Propionibacteria count at 0 hour was 1 × 107 cfu/ml |
Seventy-five cross-bred, post weaned calves weighing 650-750 pounds are randomly assigned to one of three treatments: 1.) no treatment, 2.) Propionibacterium strain P63 treated at 3.0×1011 cfu/hd, or 3.) Propionibacterium strain P63 at 1.0×109 cfu/hd and Lactobacillus acidophilus strain 53545 at 1.0×108 cfu/hd. A total of 15 pens with 5 calves per pen are blocked by sex, weight and breed prior to treatment assignment. Calves are given free access to the feed bunk and water source during the course of the experiment.
Each treatment group, consisting of steers and heifers are fed a 50:50 ration (cracked corn, cottonseed meal, alfalfa pellets and balanced for minerals) at 1.5 to 2% of BW for 14 days. During this period the appropriate treatment is added directly to the feed. The treatment dose for each individual pen is added to 600 ml of water and completely mixed with the daily ration at the time of feeding throughout the entire feeding study.
On the day following the 14-day establishment period, cattle do not receive any feed for a 24 h period. This procedure is performed in order to stimulate the engorgement of the next meal. Following the 24 hour fasting period, cattle are given a 90% concentration ration (75% cracked wheat and 25% cracked corn). This ration is fed for a total of 10 days. During this time, treatments are administered as stated above and cattle are closely monitored for signs of severe stress due to ruminal indigestion. Following the 10 day challenge period, cattle are fed a 90% concentrate diet consisting of 100% cracked corn. Cattle are fed to final weights of approximately 1,200 pounds (approx. 120 days).
All cattle are weighed at receiving and approximately every 28 days during the feeding period. Feed intake and animal health are monitored daily. Following the finishing period, cattle are transported to a packing plant at which time hot carcass weights, quality grades, yield grades, and carcass characteristics were determined.
Results. The only significant differences (p<05) in live weights are observed during the first 10 days of the study. Control cattle are 18 pounds heavier than cattle receiving the combination and 25 to 30 pounds heavier than cattle in the group which is fed P63 alone during this period. By day 27 no differences in live weight are observed (P<05). To reduce the variation resulting from bulk fill differences, final weights are determined using hot carcass weights and dressing percentages. Control carcass weights are 13 pounds heavier compared to cattle fed the combination and 18 pounds heavier than cattle fed P63 alone, however these differences are not statistically different and considered to be animal variation.
Feeding intake is reduced in cattle being fed the combination inoculum by 7.8% when compared to control animals during the first 83 days (p<0.02). Overall feed intake is 6.8% lower for the combination treatment (P<0.08) and only 2.8% lower when animals received P63 alone (not significant) when compared to controls.
The only significant difference in average daily gain is observed during the initial 10 days of the trial when cattle are abruptly switched from a 50% concentrate ration to a 90% concentrate diet containing 75% ground wheat. Cattle receiving the combination treatment gain 1.13 LB more than control cattle during this intensive adaptation period (p<0.04). Recall feed intakes during this period are not statistically different between treatment groups. Given the utilization of lactic acid and glucose by the combined inoculum the improvement in gain during this initial feeding period is expected since cattle are the most effected by ruminal indigestion at this time.
Average daily gains are slightly higher for cattle fed the combination during the first and last 30 days of the study. However, these differences are not significant. Cattle receiving P63 alone have slightly lower gains compared to control and cattle fed the combination inoculum during the entire study. Overall average daily gain (ADG) is almost identical during the 120 day feeding period.
Cattle which is fed the combination inoculum has significantly improved feed efficiencies over the entire 120 day feeding study when compared to controls. During the first 10 days of feeding, efficiency is improved by 38.4% (P<0.06) and by 10.4% (P<03) in the first 30 days when comparing cattle fed the combination to control cattle. The percent difference between treatments declines in the later periods of the feeding trial, however the significant treatment response of the combination inoculum during the initial period results in a significant treatment difference over the entire 120 day study (P<0.04).
No significant differences in carcass quality and composition are observed. The incidence of liver abscesses is relatively insignificant as compared to industry standards. Control and cattle fed P63 both have incidences of 8%. Cattle fed Lactobacillus acidophilus strain 53545 with Propionibacterium strain P63 have no liver abscesses. Generally, feedlot finished cattle will have a liver incidence of approximately 30%. Dressing percents, ribeye area, yield grades, and quality grades are similar for all treatments.
Having described the invention in detail and by reference to the preferred embodiments thereof, it will be apparent that modifications and variations are possible without departing from the scope of the appended claims.
Claims (10)
1. A ruminant direct fed microbial composition of matter comprising:
an acidosis inhibiting effective amount of Propionibacteriuin P-63; and
an animal feed material wherein said animal feed material is selected from the group consisting of corn, dried grain, alfalfa, and corn meal and mixtures thereof.
2. The composition according to claim 1 further comprising additives selected from the group consisting of growth substrates, enzymes, sugars, carbohydrates, extracts and growth promoting micro-ingredients and mixtures thereof.
3. The composition according to claim 1 further comprising a lactic acid producing culture.
4. The composition according to claim 3 wherein said lactic acid producing culture is selected from the group consisting of Lactobacillus acidophilus; Lactobacillus plantarum; Streptococcus faecium; Lactobacillus case; Lactobacillus lactis; Lactobacillus enterii; Lactobacillus fermentum; Lactobacillus delbruckii; Lactobacillus helveticus; Lactobacillus curvalus; Lactobacillus brevis; Lactobacillus bulgaricus; Lactobacillus cellobiosuus; Streptococcus lactis; Streptococcus thermophilus; Streptococcus cremoris; Streptococcus diacetylactis; Streptococcus intermedius; Bifidobacterium animalis; Bifidobacterium adolescenris; Bifidobacterium bifidum; Bifidobacterium infantis; Bifidobacterium longum; Bifidobacterium thermephilum; Pediococcus acidilactici; and Pediococcus pentosaceus and mixtures thereof.
5. A ruminant direct fed microbial composition of matter comprising:
an acidosis inhibiting effective amount of Propionibacterium P-63; and
a lactic acid producing culture wherein said lactic acid producing culture comprises Lactobacillus acidophilus ATCC 53545.
6. A swine direct fed microbial composition of matter comprising:
a scours inhibiting effective amount of Propionibacterium P-63; and
an animal feed material wherein said animal feed material is selected from the group consisting of corn, dried grain, alfalfa, and corn meal and mixtures thereof.
7. The composition according to claim 6 further comprising additives selected from the group consisting of growth substrates, enzymes, sugars, carbohydrates, extracts and growth promoting micro-ingredients and mixtures thereof.
8. The composition according to claim 6 further comprising a lactic acid producing culture.
9. The composition according to claim 8 wherein said lactic acid producing culture is selected from the group consisting of Lactobacillus acidophilus; Lactobacillus plantarum; Streptococcus faecium; Lactobacillus casei; Lactobacillus lactis; Lactobacillus enterii; Lactobacillus fermentum; Lactobacillus delbruckii; Lactobacillus helveticus; Lactobacillus curvatus; Lactobacillus brevis; Lactobacillus bulgaricus; Lactobacillus cellobiosuus; Streptococcus lactis; Streptococcus thermophilus; Streptococcus cremoris; Streptococcus diacetylactis; Streptococcus intermedius; Bifidobacterium animalis; Bifidobacterium adolescentis; Bifidobacterium bifidum; Bifidobacterium infantis; Bifidobacterium longum; Bifidobacterium thermephilum; Pediococcus acidilactici; and Pediococcus pentosaceus and mixtures thereof.
10. A swine direct fed microbial composition of matter comprising:
a scours inhibiting effective amount of Propionibacterium P-63; and
a lactic acid producing culture wherein said lactic acid producing culture comprises Lactobacillus acidophilus ATCC 53545.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/209,735 US6887489B2 (en) | 1998-04-17 | 2002-08-01 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US10/995,018 US20050214273A1 (en) | 1998-04-17 | 2004-11-22 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US11/606,456 US20070071738A1 (en) | 1998-04-17 | 2006-11-29 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8206798P | 1998-04-17 | 1998-04-17 | |
US09/292,720 US6455063B1 (en) | 1998-04-17 | 1999-04-15 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US10/209,735 US6887489B2 (en) | 1998-04-17 | 2002-08-01 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/292,720 Division US6455063B1 (en) | 1998-04-17 | 1999-04-15 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/995,018 Continuation US20050214273A1 (en) | 1998-04-17 | 2004-11-22 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
Publications (2)
Publication Number | Publication Date |
---|---|
US20030007953A1 US20030007953A1 (en) | 2003-01-09 |
US6887489B2 true US6887489B2 (en) | 2005-05-03 |
Family
ID=22168851
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/292,720 Expired - Lifetime US6455063B1 (en) | 1998-04-17 | 1999-04-15 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US10/209,735 Expired - Lifetime US6887489B2 (en) | 1998-04-17 | 2002-08-01 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US10/995,018 Abandoned US20050214273A1 (en) | 1998-04-17 | 2004-11-22 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US11/606,456 Abandoned US20070071738A1 (en) | 1998-04-17 | 2006-11-29 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/292,720 Expired - Lifetime US6455063B1 (en) | 1998-04-17 | 1999-04-15 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/995,018 Abandoned US20050214273A1 (en) | 1998-04-17 | 2004-11-22 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US11/606,456 Abandoned US20070071738A1 (en) | 1998-04-17 | 2006-11-29 | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
Country Status (3)
Country | Link |
---|---|
US (4) | US6455063B1 (en) |
AU (1) | AU3564299A (en) |
WO (1) | WO1999053775A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050214273A1 (en) * | 1998-04-17 | 2005-09-29 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
EP2245944A1 (en) | 2009-04-30 | 2010-11-03 | Danisco A/S | Method for improving the digestibility and assimilability of cereals and/or fibres in a monogastric herbivorous animal |
US7858336B1 (en) | 2010-02-01 | 2010-12-28 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US20110189147A1 (en) * | 2010-02-01 | 2011-08-04 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US9089151B2 (en) | 2011-08-24 | 2015-07-28 | Dupont Nutrition Biosciences Aps | Enzyme producing Bacillus strains |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020060199A (en) * | 1999-10-19 | 2002-07-16 | 후지야마 아키라 | Agents for promoting fattening of animals and method of promoting fattening |
US6951643B2 (en) * | 2001-07-24 | 2005-10-04 | Oklahoma State University | Direct-fed microbial |
US20030175305A1 (en) * | 2002-01-08 | 2003-09-18 | Garner Bryan E. | Compositions and methods for inhibiting pathogenic growth |
US20040028665A1 (en) | 2002-01-08 | 2004-02-12 | Garner Bryan E. | Compositions and methods for inhibiting pathogenic growth |
JP4521687B2 (en) * | 2002-06-21 | 2010-08-11 | ニューキャッスル イノベーション リミテッド | Probiotics, Propionibacterium ienseni 702 |
CA2493121C (en) * | 2002-07-22 | 2015-02-17 | Agtech Products, Inc. | Lactobacillus strains and uses therefor |
US7065674B2 (en) * | 2002-08-01 | 2006-06-20 | Microsoft Corporation | Computer system fault recovery using distributed fault-recovery information |
WO2004062388A1 (en) | 2003-01-06 | 2004-07-29 | Nutrition Physiology Corporation | Compositions and methods for reducing the pathogen content of meat and meat products |
US7384628B2 (en) * | 2003-06-23 | 2008-06-10 | Agtech Products, Inc. | Lactic acid bacteria and its use in direct-fed microbials |
US20050048515A1 (en) * | 2003-08-29 | 2005-03-03 | Garner Bryan E. | Methods for detecting and quantifying specific probiotic microorganisms in animal feed |
AU2004269388B2 (en) * | 2003-08-29 | 2009-09-17 | Nutrition Physiology Company, Llc. | Methods for detecting and quantifying specific microorganisms |
CN1324980C (en) * | 2005-08-11 | 2007-07-11 | 上海交通大学 | Method for preparing microoganism additives for ensiling lucerne |
AU2015252095A1 (en) * | 2008-12-02 | 2015-11-19 | Dupont Nutrition Biosciences Aps | Strains and methods for improving ruminant health and/or performance |
WO2010065625A1 (en) | 2008-12-02 | 2010-06-10 | Danisco A/S | Strains and methods for improving ruminant health and/or performance |
ATE541468T1 (en) * | 2009-04-30 | 2012-02-15 | Danisco | MICROBIAL FEED SUPPLEMENTS AND USES THEREOF IN METHODS FOR REDUCING AND/OR PREVENTING ACIDOSIS IN POLYGASTRIC HERBIVORIA |
EP2517715B1 (en) * | 2009-12-25 | 2017-06-28 | Meiji Feed Co., Ltd. | Composition containing propionic acid bacteria for use in preventing and/or treating acidosis |
US9011838B2 (en) * | 2010-04-20 | 2015-04-21 | Nutrition Physiology Company, Llc | Low/high dose probiotic supplements and methods of their use |
CN102106463B (en) * | 2011-01-31 | 2012-12-05 | 杨永浩 | Microbial feed additives and preparation method thereof |
US20140112889A1 (en) * | 2011-04-26 | 2014-04-24 | Dupont Nutrition Biosciences Aps | Method for reducing methane production in a ruminant animal |
PL2704704T3 (en) * | 2011-05-03 | 2019-04-30 | Dupont Nutrition Biosci Aps | Probiotic bacteria for the topical treatment of skin disorders |
RU2535111C1 (en) * | 2013-07-17 | 2014-12-10 | Государственное научное учреждение Северо-Кавказский научно-исследовательский институт животноводства Россельхозакадемии (ГНУ СКНИИЖ Россельхозакадемии) | Method of application of feed additive for pigs |
CN104489292A (en) * | 2014-11-25 | 2015-04-08 | 固镇县荣财黄牛养殖专业合作社 | Special cattle feed with functions of strengthening stomach and helping digestion and preparation method thereof |
CN110577907B (en) * | 2019-09-10 | 2021-04-16 | 中国农业科学院北京畜牧兽医研究所 | Bifidobacterium animalis and application thereof |
KR20240159671A (en) * | 2023-04-27 | 2024-11-06 | 가천대학교 산학협력단 | Bacteriophage vB_SbRt-pBovineB21 having lytic activity and biofilm control activity against Streptococcus bovis/Streptococcus equinis complex and lactic acid-producing bacteria |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4980164A (en) | 1986-10-02 | 1990-12-25 | Bio Techniques Laboratories, Inc. | Strains of lactobacillus for enhancing feed conversion efficiency |
US4981705A (en) | 1989-11-06 | 1991-01-01 | Pioneer Hi-Bred International, Inc. | Bacterial treatment to preserve silage |
US5096718A (en) | 1982-09-17 | 1992-03-17 | The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Preserving foods using metabolites of propionibacteria other than propionic acid |
US5139777A (en) | 1984-08-15 | 1992-08-18 | Richter Cedeon Vegveszeti | Composition and method for improving the efficiency of ruminant feed utilization |
US5256425A (en) | 1991-08-19 | 1993-10-26 | Bio Techniques Laboratories, Inc. | Antibiotic resistant strain of lactobacillus acidophilus |
US5529793A (en) | 1994-11-16 | 1996-06-25 | Nutrition Physiology Corporation | Compositions for improving the utilization of feedstuffs by ruminants |
US5534271A (en) | 1994-11-16 | 1996-07-09 | Nutrition Physiology | Process for improving the utilization of feedstuffs by ruminants |
US5945333A (en) | 1997-08-26 | 1999-08-31 | Ag Tech Products, Inc. | Biological poultry litter treatment composition and its use |
US6120810A (en) | 1992-03-30 | 2000-09-19 | Oklahoma State University | Bacterial composition to reduce the toxic effects of high nitrate consumption in livestock |
US6221650B1 (en) | 1997-08-25 | 2001-04-24 | Agtech Products, Inc. | Waste treatment with a combination of denitrifying propionibacterium acidipropionici and protease-producing bacillus |
US6455063B1 (en) * | 1998-04-17 | 2002-09-24 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
-
1999
- 1999-04-15 US US09/292,720 patent/US6455063B1/en not_active Expired - Lifetime
- 1999-04-15 WO PCT/US1999/008319 patent/WO1999053775A1/en active Application Filing
- 1999-04-15 AU AU35642/99A patent/AU3564299A/en not_active Abandoned
-
2002
- 2002-08-01 US US10/209,735 patent/US6887489B2/en not_active Expired - Lifetime
-
2004
- 2004-11-22 US US10/995,018 patent/US20050214273A1/en not_active Abandoned
-
2006
- 2006-11-29 US US11/606,456 patent/US20070071738A1/en not_active Abandoned
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5096718A (en) | 1982-09-17 | 1992-03-17 | The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Preserving foods using metabolites of propionibacteria other than propionic acid |
US5260061A (en) | 1982-09-17 | 1993-11-09 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Propionibacteria metabolites inhibit spoilage yeast in foods |
US5139777A (en) | 1984-08-15 | 1992-08-18 | Richter Cedeon Vegveszeti | Composition and method for improving the efficiency of ruminant feed utilization |
US4980164A (en) | 1986-10-02 | 1990-12-25 | Bio Techniques Laboratories, Inc. | Strains of lactobacillus for enhancing feed conversion efficiency |
US4981705A (en) | 1989-11-06 | 1991-01-01 | Pioneer Hi-Bred International, Inc. | Bacterial treatment to preserve silage |
US5256425A (en) | 1991-08-19 | 1993-10-26 | Bio Techniques Laboratories, Inc. | Antibiotic resistant strain of lactobacillus acidophilus |
US6120810A (en) | 1992-03-30 | 2000-09-19 | Oklahoma State University | Bacterial composition to reduce the toxic effects of high nitrate consumption in livestock |
US5529793A (en) | 1994-11-16 | 1996-06-25 | Nutrition Physiology Corporation | Compositions for improving the utilization of feedstuffs by ruminants |
US5534271A (en) | 1994-11-16 | 1996-07-09 | Nutrition Physiology | Process for improving the utilization of feedstuffs by ruminants |
US6221650B1 (en) | 1997-08-25 | 2001-04-24 | Agtech Products, Inc. | Waste treatment with a combination of denitrifying propionibacterium acidipropionici and protease-producing bacillus |
US5945333A (en) | 1997-08-26 | 1999-08-31 | Ag Tech Products, Inc. | Biological poultry litter treatment composition and its use |
US6455063B1 (en) * | 1998-04-17 | 2002-09-24 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
Non-Patent Citations (2)
Title |
---|
Database Dissertation Abstracts Online, Swinney-Floyd, Dara Lynn: "The Impact of Inoculation with Propionibacterium on Ruminal Acidosis in Beef Cattle (Lactobacillus)", retrieved from Dialog Database accession no. 01647688, XP002111092, and cross-referenced to Dissertation Abstracts International, vol. 59/05-B, 1997, p. 1928, US, Nov. 1998. |
ProQuest Digital Dissertations-Full Citation and Abstract, Swinney-Floyd, Dara Lynn: "The Impact of Inoculation with Propionibacterium on Ruminal Acidosis in Beef Cattle (Lactobacillus)", retrieved from UMI online database, Oct. 12, 1999. |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050214273A1 (en) * | 1998-04-17 | 2005-09-29 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US20070071738A1 (en) * | 1998-04-17 | 2007-03-29 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
EP2245944A1 (en) | 2009-04-30 | 2010-11-03 | Danisco A/S | Method for improving the digestibility and assimilability of cereals and/or fibres in a monogastric herbivorous animal |
US20100278796A1 (en) * | 2009-04-30 | 2010-11-04 | Danisco A/S | Method for Improving the Digestibility and the Assimilability of Cereals and/or Fibres in a Monogastric Herbivorous Animal |
US7858336B1 (en) | 2010-02-01 | 2010-12-28 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US7888062B1 (en) | 2010-02-01 | 2011-02-15 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US20110189147A1 (en) * | 2010-02-01 | 2011-08-04 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US8445226B2 (en) | 2010-02-01 | 2013-05-21 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US9267107B2 (en) | 2010-02-01 | 2016-02-23 | Microbios, Inc. | Process and composition for manufacture of a microbial-based product |
US9089151B2 (en) | 2011-08-24 | 2015-07-28 | Dupont Nutrition Biosciences Aps | Enzyme producing Bacillus strains |
US10058110B2 (en) | 2011-08-24 | 2018-08-28 | Dupont Nutrition Biosciences Aps | Enzyme producing bacillus strains |
Also Published As
Publication number | Publication date |
---|---|
AU3564299A (en) | 1999-11-08 |
US6455063B1 (en) | 2002-09-24 |
WO1999053775A1 (en) | 1999-10-28 |
US20070071738A1 (en) | 2007-03-29 |
US20030007953A1 (en) | 2003-01-09 |
US20050214273A1 (en) | 2005-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6887489B2 (en) | Propionibacterium P-63 for use in direct fed microbials for animal feeds | |
Krehbiel et al. | Bacterial direct-fed microbials in ruminant diets: Performance response and mode of action | |
Sun et al. | Effects of Bacillus subtilis natto on milk production, rumen fermentation and ruminal microbiome of dairy cows | |
Seo et al. | Direct-fed microbials for ruminant animals | |
Abe et al. | Effect of administration of bifidobacteria and lactic acid bacteria to newborn calves and piglets | |
Kritas et al. | Effect of Bacillus licheniformis and Bacillus subtilis supplementation of ewe's feed on sheep milk production and young lamb mortality | |
US8722058B2 (en) | Bacillus strains and methods for reducing E. coli disease and enhancing performance | |
US5529793A (en) | Compositions for improving the utilization of feedstuffs by ruminants | |
RU2528859C2 (en) | Isolated strain (versions) providing improvement in ruminant's health, method for preparing it, and method for administering it into ruminants | |
US20050244391A1 (en) | Compositions and methods for inhibiting pathogenic growth | |
US20030175305A1 (en) | Compositions and methods for inhibiting pathogenic growth | |
WO1989005849A1 (en) | Lactic acid bacteria for use in fermented milk products and veterinary compositions | |
WO1994003195A1 (en) | Probiotic for control of salmonella | |
PL192776B1 (en) | Fodder for horses, bacterial strain lactobacillus plantarum ji:1, lactobacillus species ac:3, and application of strain lactobacillus plantarum ji:1 | |
WO2016120405A1 (en) | Composition for use in preventing and/or treating diarrhea in animals | |
US20150224154A1 (en) | Low/High Dose Probiotic Supplements And Methods Of Their Use | |
CA2100774C (en) | Feed additive and method | |
US7384628B2 (en) | Lactic acid bacteria and its use in direct-fed microbials | |
JPWO2005087240A1 (en) | Antidiarrheal agent for livestock and poultry | |
Newman et al. | Microbial feed additives for pre‐ruminants | |
Parrott | Selection of Propionibacterjumstrains Capable of Utilizing Lactic Acid from in Vitro Models | |
Davidson | Isolation, Characterization and Utilization of Propionibacterium as a Direct-fed Microbial for Beef Cattle | |
Thomas | Supplementation of two novel probiotics in the diet of lactating dairy cows | |
Fernand | Use of Probiotic Bacterial Strains and Cell Extracts to Inhibit Acidosis and Liver Abscesses in Cattle | |
WO2024254006A1 (en) | Combination of bacterial strains to inhibit pathogens in animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |